Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing; Draft Guidance for Industry

NonrulemakingOtherFDA-2026-D-1255-0002
🔔 Subscribe
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Apr 15, 2026
Agency
Food and Drug Administration (FDA)
© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets